TLDR:

A zombie fund is a private equity or venture capital fund that has passed its investment period, has poor-performing or illiquid investments, and cannot raise a new fund, leaving LPs unable to exit their positions.

Zombie Fund Lifecycle

Zombie funds typically arise when a VC fund’s investment period ends without sufficient portfolio traction to justify raising a successor fund. The GP continues to manage existing portfolio companies — often with minimal staff and resources — funded by management fees on remaining invested capital. From an LP perspective, a zombie fund is a poor outcome: management fees continue while returns are uncertain, the GP has limited incentive to maximize value, and portfolio companies receive diminished support.

LPs facing zombie fund situations have several options. They can sell their LP interests in secondary markets at a discount, providing immediate liquidity at the cost of future upside. They can negotiate GP replacements, bringing in a new management team to extract remaining value. They can restructure through a ‘GP-led secondary’ transaction. Or they can simply wait, continuing to receive distributions as portfolio companies exit naturally. The choice depends on the size and quality of remaining portfolio assets and the LP’s own liquidity needs.

References

Living with a zombie investor

A zombie fund — past its investment period, unable to raise the next vehicle, managing out remains — changes behaviour on your cap table. Expect no follow-on reserves, slower consents (skeleton staff), heightened appetite for any liquidity (secondaries, early exits) and, eventually, LP-driven pressure to wind up positions. Founder-side responses: read the fund’s vintage and remaining term before treating its board seat as long-term, negotiate consent thresholds that cannot be blocked by an unresponsive holder, and welcome clean secondary transfers that replace the zombie with an engaged owner — while policing the SHA’s transfer mechanics so the replacement is someone you can live with. GP-side, the legal questions are fiduciary: managing conflicts between winding down fees and maximising LP outcomes, with continuation vehicles the increasingly common exit.

Related practice areaInvestment Management →